ConvaTec Group (OTCMKTS:CNVVY – Get Rating) had its target price raised by Credit Suisse Group from GBX 220 ($2.74) to GBX 225 ($2.80) in a report published on Tuesday morning, The Fly reports.
A number of other equities research analysts also recently issued reports on CNVVY. Sanford C. Bernstein began coverage on shares of ConvaTec Group in a report on Tuesday, March 7th. They issued an outperform rating on the stock. JPMorgan Chase & Co. upped their price objective on shares of ConvaTec Group from GBX 281 ($3.50) to GBX 305 ($3.79) in a research report on Friday, March 10th. Finally, Barclays upped their price objective on shares of ConvaTec Group from GBX 295 ($3.67) to GBX 300 ($3.73) in a research report on Friday, May 19th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Moderate Buy and a consensus target price of $266.25.
ConvaTec Group Price Performance
Shares of ConvaTec Group stock opened at $10.69 on Tuesday. ConvaTec Group has a 12-month low of $8.69 and a 12-month high of $12.23. The company’s 50-day moving average price is $10.70 and its 200-day moving average price is $11.03.
ConvaTec Group Increases Dividend
ConvaTec Group Company Profile
ConvaTec Group Plc operates as holding company, which engages in medical business. Its activities include development, manufacture and sales of medical products and technologies related to therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care and management, continence and critical care, and infusion devices used in the treatment of diabetes and other conditions.
- Get a free copy of the StockNews.com research report on ConvaTec Group (CNVVY)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.